Probiotics may give tamoxifen a boost in breast cancer treatment

Researchers at Wake Forest University found that probiotics may enhance the anticancer activity of tamoxifen and other endocrine-targeted medications.

(Jeanna D. Smiley/ Medical News Today)-– Next to skin cancer, breast cancer is the most common cancer among females in the United States.

Two-thirds of breast cancer tumors are sensitive to hormones like estrogen and progesterone, indicating that the tumor’s cells have receptors that use the hormones as fuel to grow.

Estrogen receptor-positive (ER+) breast cancer is the most common type of breast cancer.

However, research indicates that the breast’s unique microbiome changes with diet or the presence of tumors.

Scientists at Wake Forest University in Winston-Salem, NC, recently discovered that probiotics might amplify the anticancer effect of breast cancer drug tamoxifen, a common endocrine-targeted therapy. (…)

Categories

Categories